Steven Glendon
Lawyers
Filters
Royalty Pharma $1.3 billion senior notes offering
We advised Royalty Pharma on its SEC-registered investment-grade notes offering, including $600 million in social bonds
GeoPark $150 million notes reopening and concurrent cash tender offer
We advised GeoPark on the high-yield notes offering and the tender offer